In our two prior efficacy studies [13,14], we compared the receipt of skin cancer precision prevention materials incorporating MC1R risk with the receipt of publicly available non-genetics-based skin cancer prevention materials to determine changes in skin cancer prevention activities at two post-intervention time points and to assess potential psychosocial mediators and moderators of the intervention effect. This evidence concerns the gene MC1R and skin neoplasm.